The relationship of psychological distress, extent of disease, and performance status in patients with lung cancer

This study examined the association between two primary covariates, extent of disease (ED) and performance status rating (PSR), and the outcome of psychological distress in patients with small cell carcinoma of the lung. Patients were studied at the time of entry onto one of three Cancer and Leukemia Group B (CALGB) protocols: 7781 (N = 165) and 8083 (N = 139) for limited disease; and 7782 (N = 151) for extensive disease. Besides ED (limited versus extensive), a four‐point rating of PSR was obtained. Psychological distress was measured by the standardized Profile of Mood States (POMS). Gender, age, marital status, education, PSR, ED and two relevant interaction terms (PSR X ED; gender X ED) were analyzed using multiple linear and hierarchical regressions. Of the six main variables, gender and PSR had significant association with POMS total mood disturbance, a summary score for POMS emotional subscales, and most of the individual subscales. The PSR X ED interaction provided a rationale for testing a new regression model in which PSR and ED were combined into a single index of impairment. The final index resulted in five levels of physical impairment which bear an approximately linear relationship to increasing levels of distress (Overall regression, P < 0.001). These data suggest that PSR is an important factor in modelling POMS distress at both levels of ED, and that ED becomes an important factor with poorer performance status only.

[1]  E. Lusk,et al.  Psychosocial status of cancer patients and next of kin: Normative data from the Profile of Mood States. , 1986 .

[2]  Shelley E. Taylor,et al.  Illness‐related and treatment‐related factors in psychological adjustment to breast cancer , 1985, Cancer.

[3]  E. Lusk,et al.  Psychosocial status in chronic illness. A comparative analysis of six diagnostic groups. , 1984, The New England journal of medicine.

[4]  A McMurray,et al.  Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  J. Holland,et al.  Depression in Hospitalized Cancer Patients , 1984, Psychosomatic medicine.

[6]  S. Shacham,et al.  A shortened version of the Profile of Mood States. , 1983, Journal of personality assessment.

[7]  J. Holland,et al.  Psychological response of patients receiving two drug regimens for lung carcinoma. , 1983, The American journal of psychiatry.

[8]  R. McCorkle,et al.  Symptom distress, current concerns and mood disturbance after diagnosis of life-threatening disease. , 1983, Social science & medicine.

[9]  L. H. Maurer,et al.  Psychosocial aspects of neoplastic disease: I. Functional status of breast cancer patients during different treatment regimens. , 1980, The American journal of psychiatry.

[10]  G. Koocher,et al.  Visible physical impairment and psychological adjustment among pediatric cancer survivors. , 1980, The American journal of psychiatry.

[11]  J. Worden,et al.  The MMPI as a predictor of psychosocial adaptation to cancer. , 1979, Journal of consulting and clinical psychology.

[12]  B. Meyerowitz,et al.  Adjuvant chemotherapy for breast carcinoma: Psychosocial implications , 1979, Cancer.

[13]  H. Bingham,et al.  Psychological and social adjustment to mastectomy , 1978 .

[14]  T. Morris,et al.  Psychological and social adjustment to mastectomy. A two‐year follow‐up study , 1977, Cancer.

[15]  T. Craig,et al.  Psychiatric symptomatology among hospitalized cancer patients. , 1974, The American journal of psychiatry.

[16]  T. Craig,et al.  The quality of survival in breast cancer: A case‐control comparison , 1974, Cancer.

[17]  J. Schonfield Psychological factors related to delayed return to an earlier life-style in successfully treated cancer patients. , 1972, Journal of psychosomatic research.

[18]  M. Lorr,et al.  Two EITS Manual for the Profile of Mood States (1971 & 1992) , 1971 .

[19]  D. Karnofsky The clinical evaluation of chemotherapeutic agents in cancer , 1949 .